Am J Transplant, Volume 21, Suppl 3 Archives - Page 76 of 139 - ATC Abstracts

2021 American Transplant Congress
Impact of Pre- and Post-transplant Outcomes on Patient-reported Outcomes in a Prospective Multicenter Trial in Kidney Transplantation
J. M. Rohan¹, J. P. Leone², E. Woodle³, D. Kaufman⁴, A. R. Shields³, A. Wiseman⁵, A. J. Matas⁶, P. West-Thielke⁷, E. King³, R. R. Alloway³
¹Children's Hospital Richmond VCU, Richmond, VA, ²Tampa General, Tampa, FL, ³U Cincinnati, Cincinnati, OH, ⁴U Wisconsin, Madison, WI, ⁵Centura Transplant, Denver, CO, ⁶U Minnesota, Minneapolis, MN, ⁷UIC, Chicago, IL
*Purpose: BEST Trial (Belatacept-based Early Steroid-withdrawal Trial) compared belatacept (BELA)-based early steroid withdrawal (ESW) regimens with a tacrolimus (TAC)-based ESW regimen across 2years. CNI free/ESW…
2021 American Transplant Congress
An Unexpected Case of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Overlooked Pretransplant, but Then Diagnosed Early After Kidney Transplant with a Negative Patient Outcome: A Case Report
W. Hoffman, M. Waybill, H. Yang, D. Ladie, M. Singh
UPMC Pinnacle Transplant, Harrisburg, PA
*Purpose: ATTR-CM is underrecognized and commonly overlooked and undiagnosed. When found it is often a late diagnosis in patients with severe left ventricular hypertrophy (LVH)…
2021 American Transplant Congress
The Relevance of Naturally Occurring Non-HLA Antibody to Antibody Mediated Rejection in Patients without Anti-HLA Antibodies After Kidney Transplantation
H. Ishida¹, T. Shimizu², K. Unagami³, H. Shirakawa¹, K. Tanabe¹
¹Tokyo Womens, Tokyo 162-8666, Japan, ²Urology, Tokyo Womens, Tokyo 162-8666, Japan, ³Nephrology, Tokyo Womens, Tokyo 162-8666, Japan
*Purpose: Very few papers describe the association between non-HLA antibodies and the incidence of antibody mediated rejection (AMR) in kidney recipients. We investigated the incidence…
2021 American Transplant Congress
Evaluation of Conversion to Extended-Release Tacrolimus in Abdominal Organ and Thoracic Transplant Recipients
A. Diamond¹, N. Agarwal², A. Younas², N. Sifontis², J. Au¹, C. Ruggia-Check¹
¹Pharmacy, Temple University Hospital, Philadelphia, PA, ²Pharmacy, Temple University School of Pharmacy, Philadelphia, PA
*Purpose: An established approach for conversion from immediate-release tacrolimus (IR TAC) to extended-release tacrolimus (LCPT) in kidney transplantation exists, but is lacking in other organ…
2021 American Transplant Congress
Tacrolimus Variability Score Outperforms Coefficient of Variation in Predicting Clinical Outcomes of Living Kidney Transplantation
S. Yin, T. Song, Q. Zhong, T. Lin
Urology Institute and Organ Transplantation Center, West China Hospital, Chengdu, China
*Purpose: Intra-patient variability (IPV) was previously defined as coefficient of variation (CV) or standard deviation of Tacrolimus (Tac) exposure while none of them was easily…
2021 American Transplant Congress
Effects of Transverse Abdominis Plane Blocks on Opioid Requirements Post Kidney Donation
R. Caputo, O. Witkowsky, A. Rajab
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: There is lacking data regarding the use of transverse abdominis plane (TAP) blocks to reduce post-operative opioid requirements in kidney donors (KD). TAP blocks…
2021 American Transplant Congress
Single Center Experience in Ex Vivo Hilar Renal Artery Aneurysm Repair and Autotransplantation
A. Chang¹, K. Cederquist¹, P. Abt¹, G. Wang², B. Jackson², A. Naji¹
¹Transplant Surgery, University of Pennsylvania, Philadelphia, PA, ²Vascular Surgery, University of Pennsylvania, Philadelphia, PA
*Purpose: In this study, we review our centers experience with complex renal artery aneurysms using our preferred technique of open nephrectomy, ex vivo repair, and…
2021 American Transplant Congress
Barriers to Living Kidney Donation: A Closer Look at Declined Donors
M. Anand, S. Barhorst, S. Bumb, B. Abu Jawdeh, T. Kaur, A. Govil
University of Cincinnati, Cincinnati, OH
*Purpose: Medically complex donors are increasingly being assessed for donation. Due to concern for donor safety, there is a wide variation amongst transplant providers in…
2021 American Transplant Congress
Understanding Delays to Pediatric Kidney Transplant Wait-List Activation: Providers and Families Weigh in
C. M. Farkas-Skiles¹, A. Feinsinger², R. Pines³, A. D. Waterman⁴
¹Pediatric Nephrology, UCLA Mattel Children Hospital, Los Angeles, CA, ²Medicine and Philosophy, UCLA, Los Angeles, CA, ³Santa Barbara Cottage Hospital, Santa Barbara, CA, ⁴Nephrology, David Geffen School of Medicine, UCLA, Los Angeles, CA
*Purpose: Since timely access to kidney transplant mediates mortality of children with kidney disease, we examined which factors most commonly affect providers’ decision-making to delay…
2021 American Transplant Congress
Outcomes of Kidney Transplant Recipients with Antibody-mediated Allograft Rejection: A Retrospective Study
A. Al Jurdi¹, L. Goldfarb¹, M. Lafargue², J. Azzi³, L. V. Riella¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, ²Université de Paris, Paris, France, ³Transplantation Research Center, Brigham and Women’s Hospital, Boston, MA
*Purpose: The optimal regimen for treating acute and chronic antibody-mediated rejection (AMR) in kidney transplant recipients has yet to be established. The purpose of the…